Mabura 40mg Injection

Adalimumab is a human recombinant mAb directed against the soluble and cell-bound forms of tumor necrosis factor-alpha (TNF-α). 18 It is approved for use in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, inflammatory bowel disease, and both the skin and joint manifestations of psoriasis.